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ABSTRACT

Bobinger, Hanna, Viktoria, B. S., University of South Alabama, May 2021. Gq-Mediated
Calcium Signals in Human Airway Smooth Muscle Cells. Co-Chair of Committee: Rich,
Thomas, C., Ph.D., Co-Chair of Committee: Leavesley, Silas, J., Ph.D.
Current asthma therapies include corticosteroids, long acting β2-adrenergic receptor
(β2-AR) agonists paired with corticosteroids, or short-acting β2-AR agonists used in rescue
inhalers. Chronic use of β-agonists results in diminished effectiveness, and use of longacting β-agonists can even exacerbate asthma symptoms; this is partly because antiinflammatory therapy does not directly address the exaggerated airway narrowing due to
excessive shortening of airway smooth muscle (ASM), which is the hallmark of asthma.1
These observations led our collaborators to investigate other potential asthma therapies –
bitter taste agonists.2 Bitter taste agonists, such as chloroquine, activate a subset of Gqcoupled receptors known as bitter taste 2 receptors (TAS2Rs) in airway smooth muscle
cells. Activation of these receptors triggers relaxation of human airway smooth muscle
cells (HASMCs). This response is markedly different than the response to activation of
other Gq-coupled receptors, such as muscarinic receptors, which when activated trigger
contraction of HASMCs. The goal of this thesis project is to understand how different Gqcoupled receptor agonists trigger distinct responses in HASMCs. The working hypothesis
is that differences in the spatial distributions and/or kinetics (duration) of intracellular
calcium (Ca++) signals are responsible for the distinct responses. To test this hypothesis,
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HASMCs were treated with different concentrations of carbachol (1 – 50 µM), a m3
muscarinic acetylcholine receptor (m3 mAChR) agonist; chloroquine (10 – 200 µM), a
TAS2R agonist; or histamine (0.5 – 5 µM), a histamine 1 receptor (H1R) agonist, to target
different subsets of Gq-mediated receptors. HASMCs were loaded with Cal-520® AM, a
green-fluorescent dye that, upon binding to intracellular Ca++, increases its fluorescence
intensity. Change in intracellular Ca++ following agonist addition were visualized and
measured over time using an Andor WD spinning disk confocal microscope. Distinct
spatial differences in Ca++ signals in response the agonist addition were quantified by
measuring two parameters – Ca++ signal maximum intensity in the identified signal areas
over time and Ca++ signal area changes over time. Distinct kinetic differences in Ca++
signals were quantified by measuring two more parameters: Ca++ signal duration and the
number of identified Ca++ responses induced by each agonist per experiment. Furthermore,
the distinct changes in peak intensity, signal area, duration, and number of induced Ca++
signals were analyzed for possible concentration dependencies, which could provide future
insight into the unique airway responses induced by each agonist.

xv

INTRODUCTION

Second messenger signals, including Ca++ signals, simultaneously orchestrate
dozens of cellular functions. They have been the subject of extensive study for the last 70
years. However, the mechanisms underlying specificity in signal transduction pathways
remain unclear. Increases in intracellular Ca++ have historically been known to induce
ASM contraction, leading to constriction of the airways. One class of G protein-coupled
receptors (GPCRs), Gq-coupled receptors, regulates increases in intracellular Ca++ upon
binding of an endogenous ligand or exogenous agonist. However, activation of a particular
subset of Gq-coupled receptors, TAS2Rs, paradoxically induces ASM relaxation despite
causing increases in intracellular Ca++.3 This unique downstream effect, despite an increase
in cytosolic Ca++ via the same pathway, underscores the integral role of second-messenger
(e.g. Ca++) specificity in determining critical cellular functions via the Gq-coupled receptor
signal transduction pathway. Specifically, this observation by Conaway, Nayak, and
Deshpande highlights the importance of understanding how differences in the spatial and
kinetic distributions of intracellular Ca++ signals contribute to distinct airway responses.
In general, signaling through GPCRs plays an integral role in determining airway
response upon binding of an agonist or ligand. GPCRs are ubiquitously-expressed
receptors that contain 7 membrane-spanning α-helices, which are separated by alternating
intracellular and extracellular regions.4 There are almost 1,000 different types of GPCRs
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found in the human genome, which are specific to particular agonists.5 When an agonist
binds to a GPCR, the heterotrimeric G protein associated with that receptor is activated.
The G protein is called heterotrimeric because it has three different subunits (α, β, and γ).
In general, there are four subfamilies of GPCRs (Gs, Gi/o, Gq, and G12/13) based on the type
of G protein that the receptor interacts with, and all four subfamilies are expressed in
HASMCs.6 Each subfamily is classified by the different type of α subunit composed in its
G protein that is activated and involved in signal transduction.6 The class of GPCRs
expressed on HASMCs that will be studied in the context of airway relaxation or
constriction are Gq-coupled GPCRs, specifically TAS2Rs, H1Rs, and m3 mAChRs. For
reference, all three of the aforementioned receptors are further coupled to different subsets
of Gq-coupled receptors. For example, TAS2Rs are associated with the gustducin Gq α
subunit.7
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CHAPTER I: CURRENT ASTHMA THERAPIES

Asthma is characterized by excessive narrowing of airways in response to specific
or non-specific stimuli, and ASM is primarily responsible for this narrowing.8 The majority
of current asthma treatments directly target GPCRs or their downstream signals, including
the β2-AR, which is coupled to the Gs α subunit.6 β-adrenergic agonists, such as epinephrine
(the first bronchodilator) and isoprenaline derivatives, are used today in rescue and
maintenance inhalers for asthmatic patients.9 Currently, inhaled short-acting β2-AR
agonists (SABAs), such as albuterol, are the first treatment of choice during acute asthma
attacks as they are the most potent bronchodilators that have been approved.6,10 SABAs are
also widely used as the second line of defense to manage chronic asthma symptoms, such
as airway narrowing, because they are historically known to relax their principal target –
ASM. Long-acting β-agonists (LABAs), such as salmeterol and formoterol, have longer
half-lives upon binding to β2-ARs and offer symptomatic relief of chronic asthma.10
Furthermore, LABAs utilized in combination with inhaled corticosteroids are the first line
of defense in controlling chronic asthma symptoms. Evidence suggests that this
combination therapy enhances the anti-inflammatory effects that either drug could achieve
individually.11 One specific combination includes formoterol/budesonide due to its quick
onset of action.10 Beyond inhaled corticosteroids, LABAs, and SABAs, long-acting
muscarinic antagonists (LAMAs) and short-acting muscarinic antagonists (SAMAs) are
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also currently available, third- or fourth-line chronic asthma treatment options. They are
utilized for asthmatics for whom LABAs and SABAs are insufficient. LAMAs include
tiotropium and ipratropium, which are Gq-coupled receptor antagonists that bind to
muscarinic receptors M1, M2 and M3 to block acetylcholine (a Gq receptor contractile
agonist), leading to decreases in bronchoconstriction. However, only tiotropium has
received approval for use in managing asthma, whereas other LAMAs are currently used
in the treatment of chronic obstructive pulmonary disease and have yet to be developed
and approved as asthma drugs.10
SABAs and LABAs exhibit similar mechanisms of actions albeit with varying
durations of action. Once a SABA or LABA binds to the β2AR, the receptor undergoes a
conformational change, and the Gs α subunit is activated. Upon activation, the α subunit
binds to and activates adenylyl cyclase (AC), which is bound to the membrane. Activated
AC utilizes adenosine triphosphate (ATP) from the cytoplasm to form cyclic adenosine
monophosphate (cAMP), which is a second messenger signal. cAMP’s principal function
is to activate protein kinase A (PKA) because cAMP has a high binding affinity for
domains in PKA’s regulatory region. Activated PKA subsequently phosphorylates certain
Gq-coupled receptors and phospholipase C (PLC), inhibiting Ca++ flux, which has
historically been known to trigger ASM contraction. PKA also phosphorylates inositol
1,4,5-triphosphate (IP3) receptors, thereby reducing transport of Ca++ into the cytoplasm
from IP3-specific stores. Furthermore, PKA phosphorylates myosin light chain kinase to
decrease its affinity to calcium-calmodulin, which reduces myosin light chain
phosphorylation that would otherwise allow for ASM contraction.6
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However, the common combination of β-adrenergic agonists and corticosteroids is
not effective in long-term control of asthmatic symptoms.9 Studies have indicated
associations between inhaled or oral β2-AR agonists and an increased risk of cardiovascular
death, ischemic heart disease, and cardiac failure.12 Furthermore, SABAs have been shown
to cause airway hyperresponsiveness to specific and non-specific stimuli, leading to
increased airway inflammation.13 Moreover, when asthmatics contract infections, such as
influenza or pneumonia, rescue inhalers are less effective at inducing airway relaxation.
Because the combination of β-adrenergic agonists and corticosteroids is not effective in
long-term control of asthma-related symptoms9, alternative or complementary strategies
for the treatment of asthma are currently being explored.
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CHAPTER II: Gq-COUPLED RECEPTORS

2.1 Gq-Coupled Ca++ Signal Transduction Pathway
Historically, Gq-coupled receptors have been known as the principal mediators of
ASM contraction.6 However, bitter taste receptor agonists, which also activate Gq-coupled
receptors, offer alternative pathways to achieve ASM relaxation. Activation of bitter taste
receptors with bitter taste receptor agonists, such as chloroquine, has been shown to achieve
relaxation of HASMCs2; this is in stark contrast to other Gq-coupled receptor agonists, such
as histamine and carbachol, which trigger HASMC contraction (Figure 114).6 Originally, it
was thought that bitter taste receptors were expressed on human ASM as avoidance
receptors for toxic inhalants, leading to contraction of the airways.2 Although bitter taste
agonists follow the same signal transduction pathway as contractile Gq agonists,
differences in their intracellular Ca++-induced signals may explain the different airway
responses observed. Furthermore, bitter taste agonists offer the potential to address the
aforementioned shortcomings of current asthma therapies. Specifically, current therapies
do not address progressive airway remodeling. Bitter taste agonists not only induce
bronchodilatory effects but also inhibit allergen-induced inflammatory responses, regulate
ASM cell proliferation, and reduce airway remodeling.11 Furthermore, it was observed that
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bitter taste agonists induce a 3-fold greater dilation of airways than β-agonists in an asthma
mouse model.2 Therefore, bitter taste agonists are currently being explored for future

Figure 1.14 Subsets of Gq-coupled receptors responsible for distinct airway
responses upon binding of specific agonists.

implementation as alternative or add-on therapies to address the shortcomings of current
asthma treatments.
It is hypothesized that the induced intracellular Ca++ signal location and kinetics are
responsible for the distinct responses of ASM to activation of various Gq-coupled receptors,
thus leading to either relaxation or constriction of airways. To understand these differences,
the GPCR signaling pathway for Gq-coupled receptors must first be understood.
Gq protein-coupled receptors transduce a second-messenger signal (e.g. Ca++) to the
interior of cells via interactions with guanine nucleotide regulatory binding proteins.9 In
general, when a ligand or agonist extracellularly binds to and activates a GPCR, the GPCR
undergoes a conformational change and exposes a high-affinity binding site for a G protein
in its guanosine diphosphate (GDP)-bound inactive state. Specifically, the receptor
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interacts with the C-terminus of the α subunit of a membrane-bound, heterotrimeric,
inactive G protein, such as Gq. This binding or coupling of a G protein to a GPCR releases
GDP and thus creates an empty nucleotide binding pocket for guanosine-5’-triphosphate
(GTP); GTP exists at a higher concentration than GDP in the cytosol. Binding of GTP
causes the dissociation of the α subunit from the Gβγ dimer and activates the G protein.
Once the G protein is activated, because the γ subunit is still bound to GTP, the G protein’s
effector

domain

is

exposed,

activating

PLC.

PLC

promotes

hydrolysis

of

phosphatidylinositol 4,5-bisphosphate (PIP2) into intracellular messengers diacylglycerol
(DAG) and IP3. IP3 subsequently translocates and binds to IP3 receptors located on
sarcoplasmic reticulum Ca++ stores. Activating the IP3 receptors opens Ca++ channels, and
Ca++ can efflux into the cytosol. This increase in intracellular Ca++ is a major source of
Ca++’s role in ASM contraction.6 The goal of this work is to identify how agonists targeting
different Gq receptors, despite triggering the same Gq protein signal transduction pathway,
may lead to spatial and kinetic (duration) differences in Ca++ gradients, ultimately
determining if ASM will relax or contract.
While the Gs-coupled β2-AR signaling cascade induces ASM relaxation in response
to a β2-agonist, historically, signaling via Gq-coupled receptors in ASM has promoted ASM
contraction with transmembrane cascades that occur via the classic Gq pathway (Figure 2).
For example, the H1R is a Gq-coupled receptor capable of inducing significant ASM
contraction in vivo or ex vivo.6
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Figure 2. Gq GPCR Ca++ signal transduction pathway. Gq receptors binding an agonist can activate a
signal transduction pathway to ultimately increase intracellular Ca++ concentration. IP3 and DAG are
generated from PLC activation, leading to activation of IP3 receptors in the sarcoplasmic reticulum, which
triggers release of Ca++. Ca++ can then bind to the Cal-520® AM fluorescent sensor in the cytoplasm, which
increases its fluorescence, indicating increases in intracellular Ca++.

2.2 Maintaining ASM Tone (The Contractile State) and Aberrant GPCR Signaling
ASM contractile state is a function of the net sum of GPCR-mediated procontractile and pro-relaxant signals which ultimately establish the level of Ca++, the key
contractile signaling molecule, in the ASM cell. Additionally, the ASM contractile state is
a function of the cell’s contractile machinery response to Ca++. Furthermore, ASM is
innervated by postganglionic parasympathetic nerves releasing acetylcholine in order to
control resting ASM tone, and activation of specific GPCRs in ASM has a direct impact
on the contractile state of ASM.6 The m3 mAChR, which the agonist carbachol binds to,
also maintains the contractile state of ASM, known as maintaining ASM “tone”.6
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Changes in maintenance of the ASM contractile state are the primary causes of
increased airway resistance, which is a defining feature of asthma, and thus a cause of
exacerbation of symptoms after long-term use of β-agonists.6 The asthmatic airway is
unable to properly maintain the ASM contractile state due in part to aberrant GPCR
signaling in ASM, which contributes to elevated ASM tone. The normal GPCR signaling
pathway that induces ASM contraction establishes the level of Ca++ in the ASM cell and
may be altered at three different levels in the asthmatic airway (Figure 3).6 On the first
level, HASMCs could be exposed to a greater concentration of agonists targeting Gqcoupled receptors, which generally promote contraction, and/or a decreased concentration
of agonists that promote ASM relaxation by targeting Gs-coupled receptors. Furthermore,
stimulation of ASM with multiple contractile Gq-coupled receptor agonists has been shown
to have a synergistic effect on contraction, further exacerbating the elevated ASM tone.15
This increased or decreased access of pro-contractile and pro-relaxant agonists,
respectively, may be linked to the increased shedding of airway epithelium in the asthmatic
airway. On the second level, Gq-coupled receptor signaling may be hypersensitized, or Gscoupled receptor signaling may be desensitized, which promotes increased PIP2 hydrolysis
and thus increased intracellular Ca++ mobilization. Lastly, on the third level, the cell’s
contractile response to Ca++ may be exaggerated due to increased myosin light chain
phosphorylation.

10

Figure 3. Aberrant GPCR signaling in ASM.6 Alteration of the normal GPCR signaling pathway in ASM
can occur at three different points in the asthmatic airway, ultimately leading to elevated ASM tone.

It has specifically been shown that long-term β-agonist therapy, one of the most
widely used drug therapies in the treatment of asthma, affects the second level (receptor
expression and coupling) of the GPCR signaling pathway in ASM. Long-term β-agonist
therapy promotes the sensitization of pro-contractile GPCR signaling and desensitization
of pro-relaxant GPCR signaling, exacerbating bronchial hyperresponsiveness in
asthmatics. Mak et al. have demonstrated that exposure of ASM ex vivo to β-agonists upregulates both tachykinin (NK2)16 and H1 receptors17, which could be connected to a
mechanism whereby increased pro-contractile GPCR signaling promotes bronchial
hyperresponsiveness.

11

It is worth noting that while ASM cultures (ex vivo) are powerful experimental
models due to the fact that ASM cells in culture maintain physiologic levels of most
signaling components (receptors, effectors, and downstream signaling intermediates), the
model’s weak point lies in the decreased expression of Gq-coupled receptors such as the
m3 mAChR.6
Since it has recently been discovered that activation of Gq-coupled TAS2Rs with
bitter taste receptor agonists, such as chloroquine, triggers relaxation of HASMCs by
localized Ca++ signaling2, further investigation is warranted into the role of Ca++ signal
location or kinetics (duration) in the relaxation or contraction of ASM.
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CHAPTER III: CHARACTERISTICS OF CA++ SIGNALING

3.1 Ca++ Influx from the Extracellular Environment
While activation of Gq-coupled receptors induces increases in intracellular Ca++ as
detailed previously, the major contributors to increases in intracellular Ca++ are voltagedependent Ca++ channels (VDCCs). Activation or opening of VDCCs is primarily sensitive
to changes in voltage or exogenous, pharmacological Ca++ channel blockers. VDCCs can
mediate different types of Ca++ signals such as global increases in intracellular Ca++, Ca++
flashes, and Ca++ “sparklets.”18 In smooth muscle cells, depolarization of the membrane
from its resting potential can lead to ubiquitous elevations in Ca++, whereas
hyperpolarization lowers the concentration of intracellular Ca++. Similarly, smooth muscle
can also exhibit action potentials, or transient changes in membrane potential which allow
Ca++ entry through VDCCs into ASM cells. This transient, rapid increase in global
intracellular Ca++ concentration is visualized as a Ca++ flash. Ca++ flashes can be initiated
by the spontaneous release of endogenous ligands. On the other hand, localized Ca++
signals caused by the opening of a VDCC are referred to as Ca++ sparklets, as opposed to
the global Ca++ flashes. Ca++ sparklets are mostly stationary events that occur in specific
regions.18
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3.2 Ca++ Signal Compartmentalization (Ca++ Sparks)
Because we sought to identify and characterize the spatial and temporal differences
in agonist-induced Ca++ signals in HASMCs, it is important to note that localized
intracellular Ca++ signals can manifest as Ca++ sparks (puffs) or waves. In general, smooth
muscle cells form a continuous layer and are found in the walls of hollow organs such as
the airways; therefore, they are integral in regulating the contraction of functional organs.
As noted earlier, specifically in the context of airway contraction, hollow organ function is
regulated by changes in intracellular Ca++ concentration. However, these concentration
changes can manifest in a variety of ways, both spatially and temporally. According to
Hill-Eubanks, Werner, Heppner, and Nelson, Ca++ changes may be transient or prolonged
and may be stationary, propagating, or oscillatory.18 Increases in intracellular Ca++ usually
originate from Ca++ stores in the sarcoplasmic reticulum. Once an agonist binds to a Gqcoupled receptor, PIP2 is hydrolyzed, and one of the products of hydrolysis is IP3.
Therefore, the intracellular concentration of IP3 increases, and IP3 binds to IP3 receptors.
As mentioned previously, when IP3 binds to specific IP3 receptors in the sarcoplasmic
reticulum upon initiation of the Gq signaling pathway, activated IP3 receptors release Ca++
from stores in the sarcoplasmic reticulum into the cytosol, leading to characteristic Ca++
signals.18 Moreover, Ca++ release from IP3 receptors can lead to Ca++-induced Ca++ release.
According to Hill-Eubanks et al., Ca++ released by activated IP3 receptors is regulated by
IP3 and Ca++, both functioning as second messengers. Released Ca++ can aggregate in
higher-concentration (low micromolar) levels in the vicinity of the Ca++ channel, once
again activating IP3 receptors. At even higher concentrations outside the IP3 receptors, the
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channel becomes inactivated, thus contributing to a variety of spatially and kinetically
unique Ca++ signals. Furthermore, according to Hill-Eubanks et al., IP3 receptor-mediated
Ca++ release is transient and localized, known as Ca++ “sparks” or “puffs.” Ca++ puffs can
subsequently lead to intracellular Ca++ waves.
Ca++ waves, on the other hand, are increases in intracellular Ca++ that propagate
across the entire smooth muscle cell area (i.e. non-localized) from an initial origination
point.18 As Ca++ that is released from the sarcoplasmic reticulum acts on individual adjacent
IP3 receptors or IP3 receptor clusters, the signals cascade along these receptors. These
waves are maintained by continuously restoring Ca++ to its stores in the sarcoplasmic
reticulum and subsequently releasing it again.
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CHAPTER IV: FLUORESCENCE MICROSCOPY

4.1 Ca++ Fluorescent Dye: Cal-520® AM
Ca++-sensitive fluorescent dyes allow the quantitative measurement of changes in
intracellular Ca++ levels in cells. Fluorescent dyes can absorb specific wavelengths of light
and release energy in the form of light at longer wavelengths. When Ca++ binds to Ca++sensitive indicators, the fluorescence properties of the indicators change. Recent
developments of fluorescent dyes enable the detection of rapid Ca++ signal changes, even
within milliseconds. Fluorescent dyes are commonly loaded into cells via incubation with
the membrane-permeant acetoxymethyl (AM) ester form of the dye, which is attached to a
fluorophore. The AM form can readily pass through the cell’s plasma membrane. Once the
AM form is inside the cell, intracellular esterases cleave the ester bond to release the free
anion (negative charge), which cannot pass through the plasma membrane and thus stays
inside the cell to bind to Ca++. Fluorescent Ca++ indicators are usually derivatives of the
Ca++ chelator, namely 1,2-bis-(2-aminophenoxy)ethane-N,N,N’,N’-tetraacetic acid
(BAPTA), which is used for ratiometric and nonratiometric Ca++ measurements.
Nonratiometric dyes show increases in fluorescence intensity by binding intracellular
Ca++.18 Fluorescent Ca++ signal indicators were originally developed by Roger Tsien.19
According to Tsien, BAPTA and its derivatives are ideal as they are not significantly
affected by pH changes.20 This means that BAPTA derivatives such as Cal-520® are less

16

sensitive to the loading conditions, thereby decreasing variability between experiments. In
low-concentration environments of Ca++, once the dye is excited by a laser, induced
electron transfer from the Ca++ chelator inhibits fluorescence of the fluorophore. When
intracellular Ca++ concentration increases, this electron transfer is blocked, subsequently
resulting in changes in fluorescence intensity. Fura-2 was the first commonly used Ca++
indicator and was a ratiometric probe, meaning it required excitation by wavelengths in the
UV region of light, which proves toxic to cells. Thus, single wavelength Ca++ indicators,
such as Fluo-4, were developed to bind intracellular Ca++ and are utilized to study rapid
intracellular Ca++ intensity gradients. These single wavelength Ca++ indicators operate
within the visible light spectrum, usually requiring blue excitation wavelengths and
emitting at green wavelengths.19 According to Lock, Parker, and Smith, Cal-520® is the
optimal Ca++ fluorescent indicator for detecting and measuring local Ca++ changes over
time.19 Changes in the Cal-520® probe intensity directly indicate changes in intracellular
Ca++ concentration.
4.2 Spinning Disk Confocal Microscopy
To determine how spatial and kinetic differences of Ca++ signals contribute to
airway relaxation or constriction, differences in global or localized Ca++ signals must be
measured at high speeds. In other words, characterization of dynamic intracellular Ca++
signals requires high temporal and spatial resolution. Spinning disk confocal laser
microscopy (SDCLM) helps to overcome this hurdle. SDCLM illuminates samples with
rotating patterns of thousands of pinholes to completely illuminate all points on the sample
simultaneously. Traditional imaging techniques include confocal laser scanning
microscopy, where a tradeoff between image resolution and speed exists because the laser
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beam must scan each point separately to generate an image. On the other hand, SDCLM
utilizes an expanded beam to illuminate an array of lenses on the collector disk. Each lens
is associated with a pinhole on the pinhole disk, where both disks are fixed to a common
shaft and separated by the focal length of the lens. Exciting the sample while
simultaneously spinning both disks allows an array of focused laser beams to be scanned
across the sample. This allows in-focus fluorescence emission light to pass through the
pinhole disks and be reflected into the camera by a dichroic mirror. Ultimately, low-noise
images are achieved with SDCLM.21
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4.3 S8 Analysis of Ca++ Signals

Scheme 1. Signal flow charts of S8 algorithm processes.22

The S8 analysis process can be divided into two procedures, statistical noise
filtering and analysis of best-fit ellipses assigned to the areas of increased Ca++ signal
intensities. The latter can subsequently be organized into three subroutines: image
processing (A), event processing (B), and region of interest (ROI) processing (C), as
illustrated in Scheme 1.
The input to the S8 analysis software is a tiff stack (image sequence), which the
algorithm converts into a series of best-fit ellipses using a calculated threshold. Next, the
event processing subroutine determines the optimum ROI position. The minimum criteria
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to define an “event” are that the ellipses in each event must have an area greater than or
equal to a circle of 2-pixel radius and appear in at least two consecutive frames. The event
processing subroutine organizes the filtered ellipse locations into ROIs over time and
assigns an ROI at the position of each event, which captures the change in signal area over
time. Lastly, the mean intensity measurements are computed in each ROI over time, and
pre-selected statistical parameters for each pixel and ROI are calculated by the ROI
processing subroutine to generate the final outputs desired by the user.22 Historically, users
subjectively defined ROIs based on perceived areas of significant fluorescence intensity
fluctuations, and the mean intensity of all the pixels in each ROI was measured over time.
However, S8 applies a thresholding method to filter out noise from acquired twodimensional time lapse image sequences. This project utilized the Otsu thresholding
method. Ultimately, this noise filter allows S8 to rapidly assign best-fit ellipses to all
elevated Ca++ signals above the calculated noise threshold. S8 subsequently measures
signal parameters, such as the maximum intensity of a localized Ca++ signal, for each
disparate pixel and then averages these intensities for each identified ROI over time.
Further improvements to S8 allowed the measurement of signal areas over time, as
well as the identification of average signal duration and number of identified responses. In
short, S8 enables a more efficient and complete characterization of physiologic Ca++dependent signaling, capturing its spatial and temporal complexities. By analyzing
periodic, localized, and oscillating Ca++ signals, S8 paves the way for understanding how
diverse Ca++ distributions in response to various agonists underlie the regulation of
physiological processes. In this case, the four parameters of Ca++ signal maximum
intensity, Ca++ signal area, signal duration, and number of identified responses were
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utilized to quantify the spatial and temporal distributions of Ca++ signals in response to 3
Gq-coupled receptor agonists.
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CHAPTER V: EXPERIMENTAL METHODS

5.1 Cell Culture
HASMCs (cell line N120212 donor) were provided from Dr. Raymond Penn's laboratory
at Thomas Jefferson University.

5.1.1 Cell Growth Media Recipe: 1.1 DMEM with 5% FBS
1 packet of DMEM (high glucose; Gibco #11965-092) was added to 900 ml of
MilliQ H2O to achieve a 10% FBS media. 50 ml of FBS (Sigma F6178) was added into a
0.22 µm filter. SMCTM Growth Factors bFGF (human) and EGF (human) were
subsequently added to the media. Specifically, 0.5 µg of bFGF (Sigma F0291-25ug) and 2
µg EGF (Invitrogen PHG0311) were added, both per 1 L of media.

5.1.2 Cell Maintenance
1X sterile PBS (Gibco 10010-023) was prewarmed to 37°C. The aforementioned
growth media (Experimental Methods Section 5.1.1) was also prewarmed to 37°C.
Additionally, 0.25% Trypsin-EDTA (Gibco 25200-056) was prewarmed to 37°C. Media
was aspirated from the tissue culture vessel, and the prewarmed PBS was gently added to
the vessel. The vessel was tilted to ensure that the FBS serum was completely rinsed using
PBS to avoid inhibition of Trypsin by FBS in the following step. PBS was then aspirated
from the vessel. The prewarmed 0.25% Trypsin-EDTA was added to the vessel to
22

thoroughly cover the cells to facilitate detachment of cells from the vessel and disturb cellto-cell adhesions. Cells were subsequently incubated with Trypsin at 37°C for
approximately 5 minutes. The vessel was then tapped to dislodge any cells; cells were
checked to be rounded and dislodged from the vessel using the microscope. Prewarmed,
fresh media was then added to the vessel, and any cell clumps were diffused with up-anddown pipetting and rinsed to the bottom of the tilted vessel. The cell suspension was then
transferred to a 50-ml centrifuge tube and centrifuged for 3 to 5 minutes at 0.5X speed. The
media was aspirated from the cell pellet in the tube, and the pellet was resuspended in the
appropriate volume of prewarmed, fresh media. Cells were subsequently counted so that
they could be added into wells for experiments. An equal volume of cell suspension and
0.4% Trypan Blue stain (Gibco 15250-061), ~20 – 50 µL of each, were mixed into a
microfuge tube. 10 µL of the cell/blue mix was loaded into each side of a Countess slide.
Cells were then counted on the Countess Counter (Invitrogen). The volume needed for each
well was then calculated and subsequently added to the experimental wells containing 25
mm laminin-coated glass cover slips. 1 ml of the cell suspension was added to previously
prepared tissue culture vessels with prewarmed, fresh media, if needed for future
experimental wells. These vessels were placed in the incubator until further use. Cells with
~90% confluency that were previously added into experimental wells were then utilized
for imaging.

5.1.3 Cal-520® AM Loading Protocol23
To visualize intracellular Ca++ signals when excited with a 488 nm laser, cells were
loaded with 10 µM Cal-520® AM (AAT Bioquest 21130, MW = 1102.95 g/mol, Stock =
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50 µg) fluorescent indicator dye. Specifically, a 5 mM stock solution of Cal-520® AM was
prepared in DMSO. 2 µL of the stock solution was added to the working solution (500 ml
buffer + 500 ml medium), yielding a 10 µM final solution. Old medium was removed from
the well, and all of the working dye solution was added to the well. The well was
subsequently incubated for 45 – 60 minutes at 37°C and assayed within 4 hours. All
experiments were conducted at room temperature, 20 – 22°C.

5.1.4 Cover Slip and Agonist Preparation
Cells were washed and assayed in an extracellular Tyrodes 1X buffer (pH = 7.3)
containing (mM): 145 NaCl, 4 KCl, 10 HEPES, 10 D-Glucose, 1 MgCl2, and 1 CaCl2 to
mimic physiological conditions. Varying concentrations of chloroquine (Sigma C6628,
MW = 515.9 g/mol, Stock = 200 nM in dd H2O), histamine (Sigma H7125 MW = 111.15
g/mol, Stock = 1 M in dd H2O), or carbachol (Calbiochem 212385, MW = 147.20 g/mol,
Stock = 10 mM in DMSO) were prepared to target contractile vs. relaxant Gq-coupled
receptors. Carbachol treatments were left on ice until added to the cover slip, as required
by the DMSO solvent. Cover slips were transferred to an AttofluorTM with the Tyrodes 1X
buffer prior to imaging.

5.2 Revolution Andor WD Spinning Disk Confocal Microscope Image Procedure
Raw images were taken on a Revolution Andor WD spinning disk confocal
microscope in an ND2 format outputted by the Nikon Elements software. Images were
acquired using a 20X magnification air objective. Bound Ca++ was detected by exciting the
Cal-520® AM dye with a solid-state laser at 488 nm and collecting emitted fluorescence
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above 510 nm. The exposure time was set to 200 ms, and the laser power was set to 15%.
Images were acquired at an acquisition frame rate of 1.0 Hertz (Hz) or 1 frame per second
(s). Each frame was therefore assumed to correlate to one second or time point, given the
negligible time for mechanical opening and closing of the shutter between image captures.
A 15-minute (900-s) experiment time lapse yielded ~900 frames per experiment. After
acquiring baseline images for 5 minutes, varying concentrations of carbachol, chloroquine,
or histamine were added to the cover slip to stimulate increases in intracellular Ca++. The
two-dimensional raw images were subsequently converted into individual tiff files using
ImageJ. ImageJ was then used to combine the individual tiff files into a 16-bit image stack
to input into the S8 analysis software.

5.3 S8 Image Analysis Software
To accurately measure dynamic, agonist-induced intracellular Ca++ signals using
fluorescent Ca++ indicators and microscopy techniques, an automated ROI algorithm
named “S8” was employed.22 Inputs to the S8 software are two-dimensional (x-y space and
time) images that are in the tiff stack format (Figure 6) and are taken on a Revolution Andor
WD spinning disk confocal microscope. Each x-y frame is approximately associated with
one time point at the sampling rate of 1.0 Hz, and an image stack is created using the
ImageJ software24 by combining all x-y images in order to track signals over time. S8
allows for novel, automated identification of ROIs with Ca++ signals above the set
threshold; this automated identification eliminates user biases and saves time when
selecting ROIs. The novel S8 software was written in Python and developed in-house at
the USA College of Medicine.
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For a given experiment, individual ROIs in a stack were selected in an automated
(unbiased) manner if the average intensity of the Ca++ signal in a region met a certain
threshold. For this project, the Otsu thresholding method was applied to all experimental
data, and thresholding values were determined by setting Gaussian values. Once all ROIs
were selected by the S8 code, S8 not only measured the maximum intensity of the signals
over time (Figure 4), but also tracked how the ROI area increased or decreased over time
(Figure 5). Baseline amplitude (intensity) values were computed from pre-treatment
intervals (in this case, before 300 s). Intensity measurements were then scaled to fold
change (F/F0) and converted from frames to seconds by an acquisitioned frame rate. In this
case, the acquisitioned frame or sampling rate of 1.0 Hz was directly mapped to 1 frame
per s, since mechanical opening and closing of the camera shutter between images was
considered negligible. S8 identified maximum amplitudes (intensities) for each ROI for
each time point. Signal area for each ROI at each time point was computed using a rightside Riemann sum for the maximum intensity over time curve. The S8 code outputs include
a stack of processed images in tiff format which are background subtracted and noise
filtered, a pdf report, and a pickle file containing quantitative measurements of the four
measured signaling parameters over time: maximum signal intensity, signal area, signal
duration, and number of identified ROIs.
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Figure 4. Normalized maximum signal intensity over time for 5 identified ROIs during a representative
experiment of a 200 µM chloroquine addition at 300 s.
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Figure 5. Signal area over time for 5 identified ROIs during a representative experiment of a 200 µM
chloroquine addition at 300 s.
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While S8 identified 381 ROIs in the field of view for the representative experiment
shown in Figures 4 and 5, parameters for only five of these ROIs are plotted for
representation purposes. Additionally, not all ROIs are above the set intensity threshold for
the whole experiment time course of 900 s. For example, S8 no longer took measurements
for ROI 4 shown in green past 500 s. Similarly, for ROI 5 shown in black, S8 stopped
recording measurements past ~550 s. Furthermore, the first wave responses of normalized
maximum intensities only lasted ~50 – 75 s after agonist addition then returned to or
dropped below baseline values. Figures 4 and 5 were generated using the S8 output data
and also provide information on the duration that each ROI of Ca++ signals was above the
set threshold. For example, for ROIs 4 and 5, their average intensities dropped below the
threshold around 500 s, so S8 stopped measuring their parameters such as maximum pixel
intensity and signal area. By comparing all four parameter measurements at different
agonist concentrations, S8 allowed for the identification of any concentration dependencies
in the responses. ImageJ was used to apply an artificial color bar to both the raw and
processed images to track the Ca++ signal maximum intensity and area over time for each
ROI to illustrate how spatial and temporal differences in Ca++ gradients contribute to ASM
constriction or relaxation (Figures 6 and 7). Figure 7 represents the pseudo-colored
processed images outputted by S8 for a representative experiment. Using ImageJ, the
outputted image masks were subsequently binarized to obtain black and white images
illustrating the identified signal areas over time (Figure 8).

28

0s

320 s Cal-520
Intensity
Max

330 s

355 s

Min
Figure 6. Pseudo-colored raw confocal images of the time course of saturating 200 µM chloroquineinduced Ca++ signals in HASMCs. The spatial patterns and intensities of chloroquine-induced (200 µM)
Ca++ signals are shown at three time points (320 s, 330 s, and 355 s) following agonist addition at 300 s and
compared to the baseline Ca++ activity at 0 s. Note that the signals appear to be nuclear in origin and propagate
outwards to perinuclear regions of the cells. Signal intensity of the Cal-520® fluorophore is directly
correlated to the concentration of Ca++ in HASMCs.
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Figure 7 Pseudo-colored processed images of the time course of saturating 200 µM chloroquineinduced Ca++ signals in HASMCs. The spatial patterns and intensities of chloroquine-induced (200 µM)
Ca++ signals are shown at three time points (320 s, 330 s, and 355 s) following agonist addition at 300 s and
compared to the baseline Ca++ activity at 0 s. Note that the signals appear to be nuclear in origin and propagate
outwards to perinuclear regions of the cells. Signal intensity of the Cal-520® fluorophore is directly
correlated to the concentration of Ca++ in HASMCs.
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Figure 8. Black and white (binary) mask of processed images illustrating the signal area at four time
points for all detected ROIs. The chloroquine-induced (200 µM) identified Ca++ signal areas are shown at
three time points (320 s, 330 s, and 355 s) following agonist addition at 300 s and compared to the baseline
Ca++ areas detected at 0 s.
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CHAPTER VI: RESULTS AND DISCUSSION

6.1 Carbachol-Induced Ca++ Signals
The spatial propagation and intensity gradients of Ca++ signals induced by a
saturating concentration (50 µM) of carbachol, a contractile Gq agonist, are shown at three
time points (315 s, 322 s, and 360 s) following agonist addition at 300 s and compared to
the baseline Ca++ activity at 0 s for a representative experiment in Figure 9.
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Figure 9. Pseudo-colored processed images of the time course of saturating 50 µM carbachol-induced
Ca++ signals in HASMCs.

At the first time point, the basal Ca++ activity was low. Therefore, S8 did not detect
many regions in the first frame as depicted in these processed images. Shortly after the
agonist addition, many ROIs had an average intensity over the set threshold, which is
apparent in the image at 315 s when compared to the baseline image at the beginning of
the experiment. These processed images show both the area of each distinct Ca++ signal
ROI for the given time points and the intensity gradient within each ROI over time.
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These temporal and spatial propagations of Ca++ signals are illustrated through the
intensity color gradient. The above Ca++ signal responses at the four time points represented
were characterized by propagating waves, and the normalized maximum intensity versus
time course graph, analogous to the one presented in Figure 4, may show subsequent Ca++
signal waves. Additionally, as seen in the image frames at 315 s, 322 s, and 360 s, some
detected cells or ROIs overlap and cannot be detected separately by S8.
The images presented in Figure 9 for a saturating concentration of carbachol can be
compared to the responses seen in Figure 10 when HASMCs are treated with the vehicle
control (DMSO in a modified Tyrodes buffer) for carbachol. In this experiment, the vehicle
control was added at 300 s following the procedure for all the experiments performed for
this project. Minimal baseline Ca++ activity at the beginning of the experiment was
detected. 15 s after the vehicle control addition, S8 detected more regions with average
intensities above the set threshold, but there are markedly fewer identified regions than for
a saturating concentration of carbachol. The detected signal areas appear to be much
smaller than the regions detected in Figure 9. Near the end of the first wave response at
360 s, many ROIs that were previously detected had an average pixel intensity below the
threshold, so S8 stopped measuring them, as indicated by their disappearance in the frame
at 360 s.

34

0s

320 s Cal-520
Intensity
Max

330 s

355 s

Min
Figure 10. Pseudo-colored processed images of the time course of 0 µM carbachol (DMSO vehicle
control)-induced Ca++ signals in HASMCs.

Results for some concentrations were only obtained from one experiment. The
trends discussed for the following results are coupled with the recognition that additional
experiments are required to determine whether results are statistically significant. The plot
in Figure 11 panel A is a concentration-response curve showing the normalized average
maximum intensity of all the identified ROIs for each concentration of carbachol tested.
The “n” within each bar indicates the number of experiments performed for a given
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concentration. However, before the trends and interpretations from these plots can be
discussed, the S8 output data must be understood.
S8 identifies distinct regions of interest based on groups of pixels that are above the
intensity threshold it sets. S8 can record the maximum pixel intensity within each identified
ROI at every time point that the ROI is detected. The normalized values shown in Figure
11 panel A represent the ratio of the average maximum response intensity for all identified
ROIs from 300 s until the end of the experiment in response to a given concentration of
carbachol, to the average maximum baseline intensity from 0 to 60 s for all identified ROIs.
Lastly, for all concentrations with “n’s” greater than 1, averaging all maximum
“baseline” and “response” intensities allowed the calculation of the normalized average
maximum intensity for all experiments of a given concentration.
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n=1
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Figure 11. A, Normalized average maximum intensity concentration-response curve generated from
outputted S8 measurements for carbachol. B-F, Frequency distributions for carbachol.
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The distributions in Figure 11 panels B-F indicate the range of normalized
maximum pixel intensities, which were averaged to obtain the normalized average
maximum intensity concentration-response curve displayed in panel A.
The values presented in Figure 11 panels A-F were normalized to correct for any
potential differences in the Cal-520® AM loading conditions, which could result in
artificially high or low average maximum intensities. Normalizing the responses also
corrected for any baseline Ca++ firing occurring before the agonist was added. The
normalized values indicate the fold change (F/F0) in average maximum intensity from the
baseline due to the agonist addition. As seen previously in Figure 4 depicting the
normalized peak intensity graph over time for 5 representative ROIs, the peak wave
responses lasted ~50 – 75 s. Importantly, with the analysis method used to generate the
figures in this section, an average from the time of addition at 300 s to the end of the
experiment at 900 s was taken to capture all of the Ca++ wave responses. However, lower
peak intensity values due to factors such as receptor desensitization at later time points
could drive this average down, which explains why the values are close to 1.
At lower concentrations such as 0 µM and 1 µM, there was a ~5% decrease in the
average maximum intensity from the baseline. As seen in Figure 10 presenting the
processed images at four time points for a DMSO vehicle control addition, the cells did
indeed respond after the addition, although it was a control experiment. Because this value
is representative of one experiment, this increase in intracellular Ca++ concentration can
either be due to a particular cover slip having highly active VDCCs, or the vehicle addition
was made too forcefully causing the cells to stretch, activating their Ca++ channels, and
leading to depolarization and contraction. With higher concentrations of carbachol (10 and
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50 µM), there was a ~10% and 17% percent decrease in the normalized average maximum
intensity from the baseline, respectively. However, for both 10 µM and 50 µM, two of the
experiments were possible outliers that shifted these normalized values, which could be
confirmed with future experiments. Treatment with 5 µM carbachol resulted in a 32% foldchange decrease in the normalized average maximum intensity from the baseline.
Similarly, this data was obtained from one experiment, but may indicate that 5 µM
carbachol is an outlier in the aforementioned trends.
To further explore these trends, a distribution of the normalized average maximum
intensities was created for each concentration tested. For concentrations whose normalized
values were obtained from multiple experiments, the frequency of each bin was averaged
to obtain the presented values. These distributions indicate that ~50% of the normalized
average maximum intensities for each concentration were between 0 and 0.2, meaning that
the response is not multimodal. This also suggests that the response seen after treatment
with 5 µM carbachol may be an outlier, because it does not follow this trend. Instead, ~80%
of the recorded Ca++ responses exhibited a normalized maximum average intensity between
0 and 0.2.
Similar to the methods used in generating the carbachol ROI normalized maximum
intensity plot shown in Figure 11 panel A, the carbachol average ROI area concentrationresponse curve was generated by averaging the Ca++ signal area from 300 to 900 s for all
identified ROIs and is presented in Figure 12 panel A. For reference, an HASMC is ~250
µm in length and 3 – 5 µm in width on average at the z-level of the nucleus.25 While these
larger area values presented in Figure 11 panel A could suggest significant increases in
Ca++ signal area throughout an entire cell, it is likely that the S8 software could not
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consistently distinguish between two or more cells or ROIs overlapping, as indicated earlier
in Figure 10.
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Figure 12. A, Identified average signal area concentration-response curve generated from outputted
S8 measurements for carbachol. B-F, Frequency distributions for carbachol.

41

The average signal area values thus confirm what was depicted in the processed
images presented in Figure 10. For a saturating concentration of carbachol, the average
signal area detected by S8 was 173 µm2, or ~30% larger than the baseline Ca++ responses
in the control experiment and ~75% larger than the responses seen at 1 µM. The
concentration-response curve for average Ca++ signal areas further confirms that the values
obtained from treatment with 5 µM may be outliers. Additionally, receptor desensitization
may occur at higher concentrations leading to the ~10% greater average Ca++ response area
seen at 5 µM compared to 50 µM. The frequency distributions depicted in panels B-F
further indicate that 5 µM carbachol may be an outlier. While the average signal area after
agonist addition was ~30% larger for 50 µM than for the control, more experiments need
to be performed to determine if this trend holds true. Otherwise, these frequency
distributions illustrate that for all concentrations except 5 µM, ~85% of all the detected
signal areas for each concentration were smaller than 300 µm2, suggesting no concentration
dependence on Ca++ signal area in response to carbachol.
The third parameter studied was the duration of the carbachol responses after the
agonist addition at 300 s. While a ~30% increase in average signal area from 0 to 50 µM
is illustrated in Figure 12 panel A, the average signal duration concentration-response curve
in Figure 13 panel A indicates a ~72% increase in average signal duration from the control
to the saturating concentration. For a given concentration, the numbers shown represent
the average duration of all ROIs after the agonist addition was made at 300 s. For
concentrations with an “n” > 1, an average of averages was taken. The two characteristic
peaks exhibited in Figure 13 panel E show that the majority (~78%) of the responses to 10
µM carbachol are either transient (between 0 and 40 s) or propagating waves lasting longer
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than 200 s. The same trend is seen for a saturating concentration, where ~56% of the
responses are either transient or prolonged. At lower concentrations, such as 0 µM and 1
µM, the majority of the responses are transient (less than 40 s), again demonstrating that
the experiment performed for 5 µM carbachol may be an outlier. Excluding this
experiment, a general trend is apparent such that higher concentrations of carbachol (e.g.
10 µM and 50 µM) elicit an increase in Ca++ signals longer than 200 s and a loss of transient
signals.
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Figure 13. A, Average signal duration concentration-response curve generated from outputted S8
measurements for carbachol. B-F, Frequency distributions for carbachol.
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The fourth parameter studied was the number of Ca++ responses detected. Figure
14 illustrates that treatment with 1 µM carbachol resulted in a ~44% average increase in
the number of responses compared to the control experiment. However, as seen in Figure
13 panel C, over 50% of the responses to 1 µM carbachol were less than 40 s. At a low
concentration of agonist addition such as 1 µM, the large number of shorter Ca++ responses
to 1 µM carbachol may represent transient firings previously introduced as Ca++ “flashes.”
Additionally, the larger number of Ca++ signals detected at 1 µM could indicate Ca++
sparklets, which is supported by the average ROI signal area of 98.40 µm2 as shown in
Figure 12 panel A. Additionally, ~88% of the average ROI areas measured were smaller
than 300 µm2 after treatment with 1 µM carbachol. Conversely, the lower number of
responses at higher concentrations such as 50 µM could be representative of receptor
desensitization.
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Figure 14. Average number of identified ROIs concentration-response curve generated from outputted
S8 measurements for carbachol.
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6.2 Chloroquine-Induced Ca++ Signals
The spatial propagation and intensity gradients of Ca++ signals induced by a
saturating concentration (200 µM) of chloroquine, a bitter taste receptor Gq agonist that
induces ASM relaxation, are shown at three time points (320 s, 330 s, and 355 s) following
agonist addition at 300 s and compared to the baseline Ca++ activity at 0 s (Figure 15).
The images shown in Figure 15 can be compared to the responses seen in Figure
16 when HASMCs are treated with vehicle control, which for chloroquine, is water (H2O)
in a modified Tyrodes buffer. The time points chosen for these images are the same time
points presented for chloroquine in Figure 15 so that the responses can be accurately
compared.
In the representative vehicle control experiment presented in Figure 16, H2O in a
modified Tyrodes buffer was added at 300 s. However, unlike with the DMSO control
experiment presented in Figure 10, this control experiment exhibited significant Ca++
activity after the addition was made. Even for this control experiment, S8 detected 223
regions with average intensities above the set threshold. Although this is fewer detected
regions compared to the experiment presented in Figure 15 wherein 381 ROIs were
detected in response to a saturating concentration of chloroquine, there are a few
possibilities for this amplified response. Firstly, because one experiment was performed,
further experiments may show markedly different responses. Moreover, this monolayer of
HASMCs may have exhibited high baseline Ca++ activity, as illustrated in the baseline
image at 0 s included in Figure 16. Although Figure 16 presents the Ca++ responses at four
timepoints, images at subsequent time points during baseline acquisition consistently
depict high baseline Ca++ concentrations, where the red false color spans the entire area of
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some ROIs before and after the vehicle control was added. Another possibility for this
amplified baseline Ca++ response is that cells were hypersensitize or hyperresponsive to
mechanical perturbations if the vehicle addition was made too forcefully, causing the cells
to stretch, opening and activating their VDCCs, and leading to depolarization and
contraction. This increase in Ca++ concentration could specifically be mediated by
mechanosensitive receptors such as the transient receptor potential cation channel
subfamily V member 4 (TRPV4), which is a Ca++-permeable cation channel that has been
implicated in stretch mechanotrasduction in multiple cell systems and is expressed in the
adult lung.26
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Figure 15. Pseudo-colored processed images of the time course of saturating 200 µM chloroquineinduced Ca++ signals in HASMCs.
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Figure 16. Pseudo-colored processed images of the time course of 0 µM chloroquine (H2O vehicle
control)-induced Ca++ signals in HASMCs.

The normalized peak intensity concentration-response curve for chloroquine was
generated in the same manner as for carbachol and is depicted in Figure 17. Unlike
carbachol, these data represent a bimodal response, where there is a ~10% decrease in the
normalized average maximum intensity at 0 µM, 20 µM, 100 µM, and 200 µM, but a ~22%
decrease at 10 µM, thus resulting in a curve with two groups of characteristic peaks. For
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treatment with 20 µM chloroquine, both experiments exhibited similar average maximum
baseline intensities of ~150 and average maximum response intensities of ~140.
A distribution of the normalized average maximum intensity was created for each
concentration to determine if the plot in Figure 17 panel A could possibly be multimodal.
These distributions indicate that ~60 – 70% of the normalized maximum intensities for all
concentrations except 10 µM were between 0 and 0.2, whereas ~50% of the normalized
maximum intensities were between 0 and 0.2 for 10 µM. This nonuniformity in response
indicates that the normalized average maximum intensities for chloroquine may be
concentration-dependent, although future supporting data is required.
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Figure 17. A, Normalized average maximum intensity concentration-response curve generated from
outputted S8 measurements for chloroquine. B-F, Frequency distributions for chloroquine.
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The concentration-response area curve for chloroquine was similarly generated
using the same methods as for carbachol.
The average signal area values confirm what was indicated in the processed images
presented in Figures 15 and 16, where the detected Ca++ signal areas for the control
experiment were ~41% greater than for the saturating concentration. However, this could
be due to the high baseline Ca++ activity as seen in Figure 16. Otherwise, the average Ca++
signal areas increased for increasing concentrations of chloroquine. Importantly, for 20 µM
with an “n” of 2, the average signal areas were ~108 and 118 µm2 for each respective
experiment, indicating that neither experiment is a probable outlier.
Referencing the frequency distributions in Figure 18 panels B-F reflects this general
trend for chloroquine-induced Ca++ signal areas as seen in the average signal area
concentration-response curve in panel A. Likewise, excluding the control experiment, as
the average signal area increases with increasing concentration, the percentage of Ca++
signal areas smaller than 300 µm2 decreases.
Currently, fewer experiments have been collected for the Gq agonists chloroquine
and histamine. Definitive trends cannot be speculated without warranting future
experiments. Therefore, the concentration-response curves for both normalized average
maximum signal intensity and average signal area will be presented and discussed in
chapters 6.2 and 6.3. Both the ROI average signal duration and average number of
identified ROIs concentration-response curves in response to chloroquine will be
introduced in Appendix A, while the same plots albeit in response to histamine will be
introduced in Appendix B.
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Figure 18. A, Identified average signal area concentration-response curve generated from outputted
S8 measurements for chloroquine. B-F, Frequency distributions for chloroquine.
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6.3 Histamine-Induced Ca++ Signals
The spatial propagation and intensity gradients of Ca++ signals induced by a nonsaturating concentration (0.5 µM) of histamine, a contractile Gq agonist, are shown at three
time points (400 s, 435 s, and 457 s) following agonist addition at 300 s and compared to
the baseline Ca++ activity at 0 s for a representative experiment in Figure 19.
The images in Figure 19 can be compared to the responses seen in Figure 16 when
HASMCs are treated with vehicle control, which for both histamine and chloroquine, is
H2O in a modified Tyrodes buffer.
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Figure 19. Pseudo-colored processed images of the time course of non-saturating 0.5 µM histamineinduced Ca++ signals in HASMCs.

The processed images shown in Figure 19 are for a representative experiment of
the lowest concentration addition of histamine at 0.5 µM. At the start of the experiment,
the baseline Ca++ activity was high as indicated by the red spreads indicating high Cal520® fluorescence.
As seen in the processed image 100 seconds after the addition was made, although
the baseline Ca++ activity was high, there were further increases in Ca++ activity after the
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agonist addition, as more ROIs were detected. Over the course of this experiment, 506
ROIs had an average intensity above the set threshold.
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Figure 20. A, Normalized average maximum intensity concentration-response curve generated from
outputted S8 measurements for histamine. B-F, Frequency distributions for histamine.
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Figure 20 depicts the normalized peak intensity concentration-response curve that
was generated in the same manner as for carbachol and chloroquine. In this case, there was
no apparent increase or decrease in the normalized average peak intensity for the saturating
concentration when compared to the control. While the Ca++ responses to 0.5 µM histamine
may appear to be significant, it is important to note that this average value only represents
an “n” of 2. Importantly, the average peak intensity is 330 arbitrary units (A.U.) for one
experiment at 0.5 µM but only 60 A.U. for the other experiment at 0.5 µM. More data needs
to be collected at this concentration to confirm that the measured responses are replicable.
A distribution of the normalized average maximum intensities was created for each
concentration of histamine addition. Although there was no apparent increase or decrease
in the normalized average peak intensity for the saturating concentration when compared
to the control as seen in Figure 20 panel A, these distributions indicate that ~50% of the
normalized peak intensities for higher concentrations were between 0 and 0.2, whereas
~69% of the normalized peak intensities for the control experiment were between 0 and
0.2. Furthermore, ~35% of the normalized peak intensity values were between 0 and 0.2 at
lower concentrations. This suggests that the changes in peak Ca++ signal intensities induced
by histamine are in fact concentration-dependent.
Figure 21 presents the concentration-response average signal area curve for
histamine, which was generated using the same methods as for carbachol and chloroquine.
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Figure 21. A, Identified average signal area concentration-response curve generated from outputted
S8 measurements for histamine. B-F, Frequency distributions for histamine.
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The average detected signal area values confirm the signals visualized in the
processed images shown in Figures 16 and 19, where the detected Ca++ signal areas for the
control experiment were ~70% greater than the responses at 0.5 µM as presented in Figure
21 panel A. There was also a 6-fold decrease in the average Ca++ signal area detected for
the saturating concentration compared to the control as seen in Figure 21 panel A. However,
this large decrease in Ca++ signal area with increasing histamine concentration could be
due to the high baseline Ca++ activity of the control experiment observed in Figure 16.
Otherwise, the average Ca++ signal areas decrease for increasing concentrations of
histamine. Furthermore, for the 1 µM histamine treatment with an “n” of 2, the average
signal areas for each experiment were ~118 and 171 µm2, although their average peak
intensities were markedly different.
The frequency distributions confirm what is seen in panel A of Figure 21 and
illustrate that the percentage of smaller-area responses less than 300 µm2 increases directly
with concentration.
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CHAPTER VII: CONCLUSION

Ca++ signals in ASM are critical for managing the contraction or relaxation of
airways. When Gq agonists bind to Gq-coupled receptors, increases in cytosolic Ca++
consistently occur. Therefore, the goal of this project was to investigate if any spatial and
kinetic differences in these Ca++ signals exist, which could explain the different airway
responses to various Gq agonists. The novel S8 analysis software allowed quantitative
measurements of these complex signals to be made. As explained in Chapter VI and as
shown in Table 1, there were distinct spatial and kinetic differences in the induced Ca++
responses between the bitter taste agonist inducing relaxation, chloroquine, and contractile
agonists carbachol and histamine. Although all 3 agonists are Gq-coupled, specific
differences in the peak intensity, area, duration, and number of induced Ca++ signals were
observed, which could potentially explain the distinct airway responses, either relaxation
or contraction, in downstream studies. The average trends in these parameters were not
only different for carbachol, chloroquine, and histamine, but some responses were
concentration-dependent, and these responses did not follow a normal distribution.
Specifically, chloroquine binding to the bitter taste receptor resulted in a possible bimodal,
concentration-dependent response in the normalized average peak intensity that was not
found with the other agonists.
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Carbachol

Chloroquine
Histamine
Normalized Average Peak Intensity
may not be concentration-dependent possibly concentration-dependent
possibly concentration-dependent
negligible changes with increasing
bimodal
no apparent changes on average
concentration (5 µM outlier): ~50%
~70% between 0 – 0.2 (except 10
For 0 µM: ~69% between 0 – 0.2
between 0 – 0.2
µM)
For 0.5 and 1 µM: ~35% between 0 –
0.2
For 2.5 and 5 µM: ~50% between 0 –
0.2
Average Signal Areas
possibly concentration-dependent
possibly concentration-dependent
possibly concentration-dependent
~75% average increase from 1 to 50 ~137% average increase from 10 to 6-fold average decrease from 0 to 5 µM
2
µM
200 µM
percentage of areas < 300 µm
2
2
~85% < 300 µm (5 µM outlier)
percentage of areas < 300 µm
approximately increases with increasing
decreases with increasing
concentration
concentration
Average Signal Durations
possibly concentration-dependent
possibly concentration-dependent
possibly concentration-dependent
~72% average increase from 0 to 50 ~64% average increase from 0 to 200
~40% increase in average signal
µM
µM
duration from 0 to 5 µM
56 – 78% of responses are transient ~42.5% between 0 – 40 s (0, 10, and ~40% between 0 – 40 s (0 and 1 µM)
(0 – 40 s) or > 200 s (10 and 50 µM)
20 µM)
~50% between 0 – 40 s (2.5 and 5 µM)
majority of responses 0 – 40 s at
~22% between 0 – 40 s (100 and 200
lower concentrations (5 µM outlier)
µM)
Average Number of Identified Responses
may not be concentration-dependent possibly concentration-dependent
possibly concentration-dependent
~240 identified ROIs (5 µM outlier) ~71% average increase from 0 to 200 ~30% average decrease from 0 to 5 µM
µM

Table 1. Average trends detected in the spatial and kinetic data obtained for the G q receptor-coupled
agonists carbachol, chloroquine, and histamine.

Future recommendations to advance this study include collecting more data to
determine whether statistically significant differences occur. If the data are replicated,
additional parameters can be analyzed and will possibly point to more spatial and kinetics
differences between Gq agonists triggering relaxation or contraction of ASM, which could
further support downstream studies linking these differences to the distinct airway
responses. While four parameters were considered for this project, the S8 analysis software
is a powerful tool that can also investigate Ca++ signals more deeply by measuring
additional parameters over time, including the centroid of the area, the maximum area and

63

the time point it occurs, the change in intensity of a signal at each time point, the first frame
time for each ROI, the starting location or coordinates of each signal ROI, the coordinates
of the signal ROI at each time point and the intensity of each individual coordinate, and
any convergence or divergence in the detected areas. Because bitter taste agonists are
currently being explored as possible alternative or add-on treatments for asthma, studying
Ca++ signal differences between relaxant and contractile Gq agonists with these additional
signaling parameters coupled with the four studied in this project could be instrumental in
determining implementation, especially if these responses are also concentrationdependent.
Additionally, because Ca++ mediates the relaxation or contraction of ASM, future
studies could consider how these Ca++ signaling differences measured herein in response
to the 3 different Gq agonists could affect the spread of mechanical forces. Lastly, future
studies will involve measuring spatial and kinetic differences in induced intracellular Ca++
signals in HASMCs derived from asthmatic patients to determine if the observed responses
are analogous to the responses presented in this thesis with HASMCs from a healthy donor.
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Appendix A: Representative Experiments for S8-Processed Chloroquine Data
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Figure A1. A, Average signal duration concentration-response curve generated from outputted S8
measurements for chloroquine. B-F, Frequency distributions for chloroquine.
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Appendix B: Representative Experiments for S8-Processed Histamine Data
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Figure B1. A, Average signal duration concentration-response curve generated from outputted S8
measurements for histamine. B-F, Frequency distributions for histamine.
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